Effects of cigarette smoking on HDL quantity and function: implications for atherosclerosis

Area of Science:

• Cardiovascular Science
• Lipid Metabolism
• Atherosclerosis Research

Background:

• Cigarette smoking is a significant, modifiable risk factor for atherosclerosis and cardiovascular disease.
• Plasma high-density lipoprotein (HDL) cholesterol levels are inversely correlated with cardiovascular disease risk.
• Smokers exhibit lower HDL cholesterol levels compared to non-smokers.

Purpose of the Study:

• To investigate the impact of cigarette smoking on HDL cholesterol quantity and function.
• To elucidate the mechanisms by which smoking affects HDL metabolism and its atheroprotective properties.

Main Methods:

• Analysis of population studies on smoking and HDL cholesterol.
• Examination of the effects of smoking on key lipid transport enzymes, including lecithin: cholesterol acyltransferase (LCAT), cholesterol ester transfer protein (CETP), and hepatic lipase.
• Assessment of oxidative modifications to HDL in smokers.

Main Results:

• Cigarette smoking is associated with reduced HDL cholesterol levels.
• Smoking alters the activity of LCAT, CETP, and hepatic lipase, impacting HDL metabolism and subfraction distribution.
• HDL in smokers undergoes oxidative modification, leading to dysfunction and loss of atheroprotective effects.

Conclusions:

• Cigarette smoking adversely affects both the quantity and function of HDL cholesterol.
• These alterations in HDL contribute to the elevated risk of cardiovascular disease observed in smokers.